UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 282

Sortiert nach

MVA vectors expressing conserved influenza proteins protect mice against lethal challenge with H5N1, H9N2 and H7N1 viruses

PloS one, 2014-02, Vol.9 (2), p.e88340-e88340

2014

Volltextzugriff (PDF)

Immunogenicity and protective efficacy of a Vero cell culture-derived whole-virus H7N9 vaccine in mice and guinea pigs

PloS one, 2015-02, Vol.10 (2), p.e0113963-e0113963

2015

Volltextzugriff (PDF)

Modulation of the liver immune microenvironment by the adeno-associated virus serotype 8 gene therapy vector

Molecular therapy. Methods & clinical development, 2021-03, Vol.20, p.95-108

2021

Volltextzugriff (PDF)

A whole virus pandemic influenza H1N1 vaccine is highly immunogenic and protective in active immunization and passive protection mouse models

PloS one, 2010-02, Vol.5 (2), p.e9349-e9349

2010

Volltextzugriff (PDF)

Vectors based on modified vaccinia Ankara expressing influenza H5N1 hemagglutinin induce substantial cross-clade protective immunity

PloS one, 2011-01, Vol.6 (1), p.e16247-e16247

2011

Volltextzugriff (PDF)

Evaluation of OspA vaccination-induced serological correlates of protection against Lyme borreliosis in a mouse model

PloS one, 2013-11, Vol.8 (11), p.e79022-e79022

2013

Volltextzugriff (PDF)

Pre-clinical efficacy and safety of experimental vaccines based on non-replicating vaccinia vectors against yellow fever

PloS one, 2011-09, Vol.6 (9), p.e24505-e24505

2011

Volltextzugriff (PDF)

A pandemic influenza H1N1 live vaccine based on modified vaccinia Ankara is highly immunogenic and protects mice in active and passive immunizations

PloS one, 2010-08, Vol.5 (8), p.e12217-e12217

2010

Volltextzugriff (PDF)

Evaluation of the cellular immune responses induced by a non-adjuvanted inactivated whole virus A/H5N1/VN/1203 pandemic influenza vaccine in humans

Vaccine, 2010-12, Vol.29 (2), p.166-173

2010

Volltextzugriff (PDF)

Nonreplicating Vaccinia Virus Vectors Expressing the H5 Influenza Virus Hemagglutinin Produced in Modified Vero Cells Induce Robust Protection

Journal of Virology, 2009-05, Vol.83 (10), p.5192-5203

2009

Volltextzugriff (PDF)

The soluble cytoplasmic tail of CD45 regulates T‐cell activation via TLR4 signaling

European journal of immunology, 2021-12, Vol.51 (12), p.3176-3185

2021

Volltextzugriff (PDF)

Laboratory diagnosis of Lyme neuroborreliosis is influenced by the test used: Comparison of two ELISAs, immunoblot and CXCL13 testing

Journal of the neurological sciences, 2014-12, Vol.347 (1), p.96-103

2014

Volltextzugriff (PDF)

A Novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with Borrelia burgdorferi sensu lato

Clinical and vaccine immunology, 2014-11, Vol.21 (11), p.1490-1499

2014

Volltextzugriff (PDF)

Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses

Vaccine, 2007-08, Vol.25 (32), p.6028-6036

2007

Volltextzugriff (PDF)

A New Approach to a Lyme Disease Vaccine

Clinical infectious diseases, 2011-02, Vol.52 (suppl_3), p.S266-S270

2011

Volltextzugriff (PDF)

Lyme disease vaccination: safety first – Authors' reply

The Lancet infectious diseases, 2014, Vol.14 (1), p.12-13

2014

Volltextzugriff (PDF)

Comprehensive approach for identification of functional FCGR2C alleles resulting in protein expression as a determinant for predicting predisposition to autoimmunity

Immunomedicine, 2021-12, Vol.1 (2), p.n/a

2021

Volltextzugriff (PDF)

Safety and immunogenicity of a vero cell culture-derived whole-virus H5N1 influenza vaccine in chronically ill and immunocompromised patients

Clinical and vaccine immunology, 2014-06, Vol.21 (6), p.867-876

2014

Volltextzugriff (PDF)

A cell culture-derived whole-virus H5N1 vaccine induces long-lasting cross-clade protective immunity in mice which is augmented by a homologous or heterologous booster vaccination

Vaccine, 2012-08, Vol.30 (37), p.5533-5540

2012

Volltextzugriff (PDF)

Seasonal influenza vaccine elicits heterosubtypic immunity against H5N1 that can be further boosted by H5N1 vaccination

Vaccine, 2010-02, Vol.28 (7), p.1778-1785

2010

Volltextzugriff (PDF)

Preclinical evaluation of Vaxfectin®-adjuvanted Vero cell-derived seasonal split and pandemic whole virus influenza vaccines

Human vaccines & immunotherapeutics, 2013-06, Vol.9 (6), p.1333-1345

2013

Volltextzugriff (PDF)

The role of complement and gp120-specific antibodies in virus lysis and CD4+ T cell depletion in HIV-1-infected patients

Microbial pathogenesis, 1998-11, Vol.25 (5), p.253-266

1998

Volltextzugriff (PDF)

A New Approach to a Lyme Disease Vaccine

Clinical infectious diseases, 2011-02, Vol.52 (-), p.S266

2011

Volltextzugriff (PDF)

A New Approach to a Lyme Disease Vaccine: The Need for a New Lyme Disease Vaccine

Clinical infectious diseases, 2011, Vol.52

2011

Volltextzugriff (PDF)

1 – 25 von 282

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(243)
Mit Volltextzugriff
(247)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(282)
Japanisch
(20)

Erscheinungsjahr

n.n

Thema

Science & Technology
(177)
Life Sciences & Biomedicine
(145)
Humans
(117)
Female
(70)
Animals
(68)
Male
(60)
Biological And Medical Sciences
(49)
Adult
(46)
Mice
(43)
Immunology
(40)
Middle Aged
(40)
Microbiology
(32)
Fundamental And Applied Biological Sciences. Psychology
(29)
Virology
(28)
Aged
(22)
Medical Sciences
(22)
Social Sciences
(22)
Multidisciplinary Sciences
(20)
Respiratory Syncytial Virus
(20)
Science & Technology - Other Topics
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

MVA vectors expressing conserved influenza proteins protect mice against lethal challenge with H5N1, H9N2 and H7N1 viruses

Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial

Immunogenicity and protective efficacy of a Vero cell culture-derived whole-virus H7N9 vaccine in mice and guinea pigs

Modulation of the liver immune microenvironment by the adeno-associated virus serotype 8 gene therapy vector

A whole virus pandemic influenza H1N1 vaccine is highly immunogenic and protective in active immunization and passive protection mouse models

Vectors based on modified vaccinia Ankara expressing influenza H5N1 hemagglutinin induce substantial cross-clade protective immunity

Evaluation of OspA vaccination-induced serological correlates of protection against Lyme borreliosis in a mouse model

Pre-clinical efficacy and safety of experimental vaccines based on non-replicating vaccinia vectors against yellow fever

A pandemic influenza H1N1 live vaccine based on modified vaccinia Ankara is highly immunogenic and protects mice in active and passive immunizations

Evaluation of the cellular immune responses induced by a non-adjuvanted inactivated whole virus A/H5N1/VN/1203 pandemic influenza vaccine in humans

Nonreplicating Vaccinia Virus Vectors Expressing the H5 Influenza Virus Hemagglutinin Produced in Modified Vero Cells Induce Robust Protection

The soluble cytoplasmic tail of CD45 regulates T‐cell activation via TLR4 signaling

Laboratory diagnosis of Lyme neuroborreliosis is influenced by the test used: Comparison of two ELISAs, immunoblot and CXCL13 testing

A Novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with Borrelia burgdorferi sensu lato

Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses

A New Approach to a Lyme Disease Vaccine

Lyme disease vaccination: safety first – Authors' reply

Comprehensive approach for identification of functional FCGR2C alleles resulting in protein expression as a determinant for predicting predisposition to autoimmunity

Safety and immunogenicity of a vero cell culture-derived whole-virus H5N1 influenza vaccine in chronically ill and immunocompromised patients

A cell culture-derived whole-virus H5N1 vaccine induces long-lasting cross-clade protective immunity in mice which is augmented by a homologous or heterologous booster vaccination

Seasonal influenza vaccine elicits heterosubtypic immunity against H5N1 that can be further boosted by H5N1 vaccination

Preclinical evaluation of Vaxfectin®-adjuvanted Vero cell-derived seasonal split and pandemic whole virus influenza vaccines

The role of complement and gp120-specific antibodies in virus lysis and CD4+ T cell depletion in HIV-1-infected patients

A New Approach to a Lyme Disease Vaccine

A New Approach to a Lyme Disease Vaccine: The Need for a New Lyme Disease Vaccine

Suchergebnisse filtern